TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
Delayed Japan Exchange  -  02:00 2022-07-01 am EDT
3759.00 JPY   -1.55%
07/01Takeda's Takhzyro Shows 94.8% Reduction in Hereditary Angioedema Attacks in Phase 3 Trial in Children
MT
06/30TAKEDA PHARMACEUTICAL : Phase 3 SPRING study data presented at EAACI
PU
06/30Takeda's TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
07/01DOJ Says J&J Talc Bankruptcy Violates Congressional Mass Tort Rules
DJ
07/01Pharmaceutical companies still have the upper hand
06/30Pfizer Files New Drug Application For COVID-19 Antiviral Pill
MT
06/30Denmark's Genmab To Seek US FDA Nod For Blood Cancer Therapy In H2
MT
06/30U.S. FDA to use existing Omicron booster data to review shots targeting new subvariants..
RE
06/30US FDA wants COVID boosters targeting Omicron BA.4, BA.5 subvariants
RE
06/30SECTOR UPDATE : Health Care Stocks Swoon Late, Closing Lower
MT
06/30SECTOR UPDATE : Health Care Stocks Little Changed on Thursday
MT
06/30Pfizer, BioNTech Enter $3.2 Billion Deal to Provide 105 Million COVID-19 Vaccines Doses..
MT
06/30Pfizer Submits New Drug Application for Paxlovid
MT
06/30Hywin Holdings, FactSet Launch Global Health Care Index
MT
06/30Sirana Pharma Enters into Collaborative Research Agreement with Pfizer to Investigate N..
CI
06/29Pfizer, BioNTech Sign New $3.2 Billion COVID-19 Vaccine Supply Deal With US
MT
06/29Pfizer, BioNTech Enter $3.2 Billion Deal to Provide 105 Million COVID-19 Vaccines Doses..
MT
06/29--STREET COLOR : Pfizer, BioNTech Reportedly Will Receive $3.2 Billion From US Government ..
MT
06/29Pfizer, BioNTech Reportedly Strike New Deal With US Government to Deliver Additional Do..
MT
06/29Pfizer Inc. and BioNTech SE Announces New Agreement with U.S. Government to Provide Add..
CI
06/29Pfizer, BioNTech to Test Global Vaccine for COVID-19
MT
06/29Eli Lilly and Company to Supply an Additional 150,000 Doses of Abcellera-Discovered Ant..
CI
06/29Johnson & Johnson Unit Secures FDA's Breakthrough Therapy Designation For Talquetamab i..
MT
06/29Eli Lilly Bags $275 Million Deal to Supply Additional Doses Of COVID-19 Antibody Drug i..
MT
06/29Pfizer, BioNTech To Start Tests On New Shots Targeting Coronaviruses
MT
06/29BioNTech, Pfizer to starting testing universal coronavirus vaccine in H2
RE
06/29ROCHE HOLDINGS AG : JP Morgan remains Neutral
MD
06/29Eli Lilly to Provide US Government With Additional 150,000 Doses of COVID-19 Treatment ..
MT
06/29Eli Lilly and Company Will Supply an Additional 150,000 Doses of Bebtelovimab to U.S. G..
CI
06/29Eli Lilly Gets $275 Million U.S. Pact for Covid-19 Antibody Drug
DJ
06/29Correction to AbbVie Executives Article on June 28
DJ
06/29Switzerland's Roche Introduces New Tissue Staining Platform For Cancer Diagnostics
MT
06/29Roche Launches New Benchmark Ultra Plus System for Cancer Diagnostics Enabling Timely, ..
CI
06/28SECTOR UPDATE : Health Care
MT
06/28Novartis to cut up to 8,000 jobs globally
RE
06/28Abbvie Inc. Appoints Scott T. Reents as Chief Financial Officer
CI
06/28Abbvie Inc. Announces Executive Appointments
CI
06/28MeiraGTx Sees Positive Data From Phase 1/2 Trial of Botaretigene Sparoparvovec for X-Li..
MT
06/28PFIZER INC : JP Morgan sticks Neutral
MD
06/28Pfizer, Roivant Sciences Launch New Joint Biotechnology Company Focused on Autoimmune D..
MT
06/28AbbVie Names Michael President, Reents Finance Chief
DJ
06/28Roivant Sciences and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Stu..
CI
06/28Roche Launches VENTANA DP 600 slide scanner for Digital Pathology, Enhancing Patient Ca..
CI
06/27SECTOR UPDATE : Health Care Stocks Posting Modest Monday Gains
MT
06/27SECTOR UPDATE : Health Care Stocks Rising in Defensive Afternoon Trade
MT
06/27Eli Lilly and Company Declares Third-Quarter Dividend for 2022, Payable on September 9,..
CI
06/27PFIZER INC : Barclays reiterates its Neutral rating
MD
06/27Pfizer-BioNTech COVID-19 Adapted Vaccines Show Higher Immune Response Against Omicron i..
MT
06/27Eli Lilly, Innovent's Tyvyt Obtains Approval to Treat Advanced Gastric, Gastroesophagea..
MT
06/27AbbVie Says EMA's Committee Supports Approval of Upadacitinib for Treatment of Chronic ..
MT
06/27AbbVie Inc. Announces the European Medicines Agency's Committee for Medicinal Products ..
CI
06/27Innovent Biologics, Inc. and Eli Lilly and Company Jointly Announces Approval of TYVYT ..
CI
06/26Pfizer-BioNTech's Two Omicron-specific Vaccines Trigger High Immune Response Against CO..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on TAKEDA PHARMACEUTICAL COMPANY LIMITED